Heartland Oncology and Hematology Oncologist Named 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO)
Dr. Sakeer Hussain, a medical oncologist at Heartland Oncology and Hematology, has been named a 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO). The recognition was announced during ASCO's annual Advocacy Summit in Washington, D.C. Dr. Hussain was honored for his significant contributions to cancer policy advancement, including meetings with congressional leaders, testifying before the Iowa House of Representatives, and hosting his local congressman to showcase community oncology care.
His advocacy work has focused on critical issues such as drug shortages, research funding, telehealth access, prior authorization reform, and opposing non-medical switching. Dr. Hussain's efforts align with ASCO's mission to support high-quality, equitable cancer care, regardless of patients' geography, income, or background.
Il dottor Sakeer Hussain, oncologo medico presso Heartland Oncology and Hematology, è stato nominato Advocacy Champion 2025 dall'Associazione per l'Oncologia Clinica (ASCO). Il riconoscimento è stato annunciato durante l'annuale Advocacy Summit di ASCO a Washington, D.C. Il dottor Hussain è stato premiato per i suoi importanti contributi nel progresso delle politiche oncologiche, inclusi incontri con leader del Congresso, testimonianze davanti alla Camera dei Rappresentanti dell'Iowa e l'organizzazione di visite del suo deputato locale per mostrare l'assistenza oncologica nella comunità.
Il suo impegno di advocacy si è concentrato su temi fondamentali come la carenza di farmaci, il finanziamento della ricerca, l'accesso alla telemedicina, la riforma delle autorizzazioni preventive e l'opposizione al cambio non medico dei trattamenti. Gli sforzi del dottor Hussain sono in linea con la missione di ASCO di promuovere cure oncologiche di alta qualità ed eque, indipendentemente dalla posizione geografica, dal reddito o dal background dei pazienti.
El Dr. Sakeer Hussain, oncólogo médico en Heartland Oncology and Hematology, ha sido nombrado Campeón de Defensa 2025 por la Asociación de Oncología Clínica (ASCO). El reconocimiento se anunció durante la Cumbre Anual de Defensa de ASCO en Washington, D.C. El Dr. Hussain fue homenajeado por sus importantes contribuciones al avance de políticas contra el cáncer, incluyendo reuniones con líderes del Congreso, testificar ante la Cámara de Representantes de Iowa y recibir a su congresista local para mostrar la atención oncológica comunitaria.
Su trabajo de defensa se ha centrado en temas críticos como la escasez de medicamentos, la financiación de la investigación, el acceso a la telemedicina, la reforma de la autorización previa y la oposición al cambio no médico de tratamientos. Los esfuerzos del Dr. Hussain están alineados con la misión de ASCO de apoyar una atención oncológica de alta calidad y equitativa, sin importar la geografía, ingresos o antecedentes de los pacientes.
사키르 후세인 박사는 Heartland Oncology and Hematology의 의료 종양학자로서 임상종양학회(ASCO)로부터 2025년 옹호 챔피언으로 선정되었습니다. 이 수상은 워싱턴 D.C.에서 열린 ASCO 연례 옹호 정상회의에서 발표되었습니다. 후세인 박사는 의회 지도자들과의 회의, 아이오와 주 하원 증언, 지역 국회의원을 초청해 지역사회 종양 치료 현황을 소개하는 등 암 정책 발전에 크게 기여한 공로를 인정받았습니다.
그의 옹호 활동은 약품 부족, 연구 자금 지원, 원격 진료 접근성, 사전 승인 제도 개혁 및 비의료적 치료 변경 반대와 같은 중요한 이슈에 집중되어 있습니다. 후세인 박사의 노력은 환자의 지역, 소득 또는 배경에 관계없이 고품질의 공평한 암 치료를 지원하는 ASCO의 사명과 일치합니다.
Le Dr Sakeer Hussain, oncologue médical chez Heartland Oncology and Hematology, a été nommé Champion de la Plaidoyer 2025 par l'Association pour l'Oncologie Clinique (ASCO). Cette distinction a été annoncée lors du Sommet annuel de la Plaidoyer d'ASCO à Washington, D.C. Le Dr Hussain a été honoré pour ses contributions significatives à l'avancement des politiques contre le cancer, notamment ses rencontres avec des dirigeants du Congrès, son témoignage devant la Chambre des représentants de l'Iowa, et l'accueil de son député local pour présenter les soins oncologiques communautaires.
Son travail de plaidoyer s'est concentré sur des enjeux cruciaux tels que les pénuries de médicaments, le financement de la recherche, l'accès à la télésanté, la réforme de l'autorisation préalable et l'opposition au changement non médical de traitement. Les efforts du Dr Hussain s'alignent avec la mission d'ASCO qui est de soutenir des soins oncologiques de haute qualité et équitables, quel que soit le lieu, le revenu ou l'origine des patients.
Dr. Sakeer Hussain, medizinischer Onkologe bei Heartland Oncology and Hematology, wurde von der Association for Clinical Oncology (ASCO) als Advocacy Champion 2025 ausgezeichnet. Die Ehrung wurde während des jährlichen Advocacy Summit von ASCO in Washington, D.C. bekannt gegeben. Dr. Hussain wurde für seine bedeutenden Beiträge zur Weiterentwicklung der Krebs-Politik geehrt, darunter Treffen mit Kongressführern, Zeugenaussagen vor dem Repräsentantenhaus von Iowa und die Einladung seines örtlichen Kongressabgeordneten, um die onkologische Versorgung vor Ort zu präsentieren.
Sein Engagement konzentriert sich auf wichtige Themen wie Arzneimittelknappheit, Forschungsfinanzierung, Zugang zu Telemedizin, Reform der vorherigen Genehmigung und die Ablehnung nicht-medizinischer Therapieänderungen. Dr. Hussains Bemühungen stehen im Einklang mit ASCOs Mission, eine hochwertige und gerechte Krebsversorgung unabhängig von Geografie, Einkommen oder Hintergrund der Patienten zu fördern.
- None.
- None.
Sakeer Hussain, MD, was honored for his dedication to advancing cancer policy at national and state levels during ASCO’s 2025 Advocacy Summit event
COUNCIL BLUFFS, Iowa, May 14, 2025 (GLOBE NEWSWIRE) -- Sakeer Hussain, MD, a Board-certified medical oncologist at Heartland Oncology and Hematology, a partner practice of the American Oncology Network (AON), has been recognized as a 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO). The distinction was announced during ASCO’s annual Advocacy Summit held in Washington, D.C. last month.
Each year, ASCO selects Advocacy Champions who have demonstrated exceptional commitment to policy advocacy in support of high-quality, equitable cancer care. Honorees actively engage lawmakers at both the state and federal levels, champion legislative priorities, and elevate the voice of the oncology community through outreach and education.
“Advocacy Champions like Dr. Hussain are driving real change in how cancer care is delivered across the country,” said Martin Palmeri, MD, MBA, chair of ASCO’s Government Relations Committee and treasurer of the Board of Directors for the Association for Clinical Oncology. “Their efforts this year have advanced critical issues such as drug shortages, securing sustainable research funding, and advocating for permanent telehealth access. These contributions will continue to benefit providers and patients alike.”
Dr. Hussain’s advocacy work spans multiple fronts. During the past year, he has met with congressional leaders in Washington, provided testimony before the Iowa House of Representatives opposing non-medical switching, and hosted his local congressman at his clinic to highlight the value of community oncology care. He has also been a consistent voice in discussions surrounding prior authorization reform and telemedicine expansion.
“I’m deeply honored to be named an ASCO Advocacy Champion,” said Dr. Hussain. “This recognition reflects my commitment to ensuring every cancer patient—regardless of geography, income, or background—has access to the timely, high-quality care they deserve. I believe advocacy is essential to closing gaps in our healthcare system, and I’m proud to contribute to that mission.”
Dr. Stephen “Fred” Divers, chief medical officer of AON, praised the recognition, noting Dr. Hussain’s advocacy impact extends far beyond his own clinic. “Dr Hussain exemplifies the spirit of community oncology and the power of physician-led advocacy,” said Dr. Divers. “His engagement with policymakers helps secure the future of local cancer care and reinforces our network’s mission to support independent practices. We’re proud of his ongoing leadership.”
For news, advocacy, and analysis on cancer policy, please visit www.asco.org/ascoaction.
For more information about AON, visit www.AONcology.com. For more information about Heartland Oncology and Hematology, visit www.heartlandoncology.com.
About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
About Heartland Oncology and Hematology
Heartland Oncology and Hematology is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, Heartland Oncology and Hematology strives to provide the best treatment options, state-of-the-art equipment and best possible experience to patients and their families throughout the healthcare journey. Learn more at www.heartlandoncology.com.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/67cee6cc-5840-4adf-acfb-4f59bfa1361b
Media Contact: Karen Riley Sawyer American Oncology Network Karen.Sawyer@AONcology.com
FAQ
What recognition did Dr. Sakeer Hussain receive from ASCO in 2025?
What key policy issues has Dr. Hussain advocated for at AONC?
How has Dr. Hussain contributed to cancer policy advocacy in Iowa?
What is the significance of ASCO's Advocacy Champion recognition?
